Revolution medications provide preliminary data from the Zoldonrasib (RMC-9805) in patients with Kras G12D at the annual meeting of 2025 AACR

Photo of author

By [email protected]




Revolution medications provide preliminary data from the Zoldonrasib (RMC-9805) in patients with Kras G12D at the annual meeting of 2025 AACR



[og_img]

Source link

Leave a Comment